Clinical Trial Update: [18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the [18F]FES PET/CT imaging agent to detect distant metastasis in low-grade ER-positive Stage III breast cancer is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Asan Medical Center | Conditions: Stage III Breast Cancer | Phase 2 | Status: RECRUITING